The Pharmaceutical Market: Malaysia

Date: January 31, 2013
Pages: 113
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P8F52F19CD9EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Malaysia
OVERVIEW OF THE PHARMACEUTICAL MARKET IN MALAYSIA

Malaysia ' s healthcare sector is showing strong signs of growth, with increased internal and investment in pharmaceutical manufacturing facilities in a move to boost exports. Key growth areas include biotechnology; namely drug discovery, new product development , technology acquisition and licensing ; generic drug production; and the recent release of h alal pharmaceutical guidelines mean s Malaysia has the potential to take a le ading role in the fast-growing h alal pharmaceutical market. While concerns remain regarding intellectual property - Malaysia has presented objections to elements in the Trans-Pacific Partnership Agreement - it is making progress in terms of trade relations: the government began negotiations over the creation of a European Free Trade Agreement in November 2012. Malaysia suffers a burden of both communicable and non-communicable diseases, with diabetes a growing concern for pol icymakers: the government forecasts there will be 4.5mn sufferers of the disease by 2020, compared to 2.6mn in 2011.

Headline Expenditure Projections

Pharmaceuticals: MYR5.55bn (US$1.81bn) in 2011 to MYR6.1bn (US$1.93bn) in 2012; +10.2% in local currency and +6.2% in US dollars. Forecast unchanged from Q4 12.

Healthcare: MYR36.35bn (US$11.88bn) in 2011 to MYR38.85bn (US$12.24bn) in 2012; +6.9% in local currency and +3.0% in US dollars. Forecast lowered from Q4 12 on account of macroeconomic factors.

Medical devices: MYR3.97bn (US$1.30bn) in 2011 to MYR4.29bn (US$1.35bn) in 2012; +8.2% in local currency and +4.3% in US dollars. Forecast lowered from Q4 12 on account of new historical data.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Malaysia Pharmaceuticals And Healthcare Industry SWOT
    Malaysia Political SWOT
    Malaysia Economic SWOT
    Malaysia Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Asia Pacific Pharmaceutical Risk/Reward Ratings, Q113
    Rewards
    Risks

MALAYSIA – MARKET SUMMARY

REGULATORY REGIME

    Table: Drug Applications by Type, 2002-10
    Table: Registered Pharmaceutical Products by Type, 2002-10
    Regulatory Developments
    Bioequivalence
    Regional Collaboration
    Pharmaceutical And Medical Advertising
    Labelling Requirements
    Intellectual Property Regime
    Counterfeit Pharmaceuticals
    Compulsory Licensing
    Free Trade Agreements
    Pricing And Reimbursement

INDUSTRY TRENDS AND DEVELOPMENTS

    Epidemiology
    Non-Communicable Diseases
    Communicable Diseases
    Healthcare Sector
    Table: 2011 Entry Points Projects Summary
    Health Insurance
    Table: Main Features Of 1Care
    Healthcare Sector Funding
    Table: Public Sector And Private Sector Healthcare Developments
    Medical Tourism
    Biotechnology And Research
    Clinical Trials
    Clinical Trials Industry Developments
    Medical Devices
    Leading Medical Device Players
    Recent Medical Devices Industry Developments

INDUSTRY FORECAST SCENARIO

      Overall Market Forecast
      Table: Pharmaceutical Sales Indicators 2008-2016
      Key Growth Factors – Industry
      Table: Healthcare Expenditure Indicators 2008-2016
      Table: Healthcare Governmental Indicators 2008-2016
      Table: Healthcare Private Indicators 2008-2016
      Key Growth Factors – Macroeconomic
      Table: Macro Indicators
      Prescription Drug Market Forecast
      Table: Prescription Drug Sales Indicators 2008-2016
      Patented Drug Market Forecast
      Table: Patented Drug Market Indicators 2008-2016
      Generic Drug Market Forecast
      Table: Generic Drug Sales Indicators 2008-2016
      OTC Medicine Market Forecast
      Table: OTC Medicine Sales Indicators 2008-2016
      Pharmaceutical Trade Forecast
      Table: Exports and Imports Indicators 2008-2016
      Medical Device Market Forecast
      Table: Medical Devices Sales Indicators 2008-2016
      Other Healthcare Data Forecasts
      Key Risks To BMI's Forecast Scenario

COMPETITIVE LANDSCAPE

      Domestic Pharmaceutical Industry
  Foreign Pharmaceutical Industry
      Table: Leading Malaysian Pharmaceutical And Healthcare Companies
      Company Activities
      Halal Medicine
      Traditional Medicine
      Pharmaceutical Distribution
      Table: Drug Wholesalers & Importers, 2002-10

COMPANY PROFILES

  Local Companies
      Pharmaniaga
      Prime Pharmaceutical
      Bumimedic
      Hovid
      Chemical Company of Malaysia
      Kotra Pharma
  Multinational Companies
      GlaxoSmithKline
      Pfizer
      Novartis
      Merck & Co
      Sanofi
      Eli Lilly Malaysia
      Ranbaxy Malaysia

DEMOGRAPHIC OUTLOOK

© BUSINESS MONITOR INTERNATIONAL LTDPAGE

  Malaysia Pharmaceuticals & Healthcare Report Q1 2013
    Table: Population By Age Group, 1990-2020 ('000)
    Table: Population By Age Group, 1990-2020 (% of total)
    Table: Key Population Ratios, 1990-2020
    Table: Rural/Urban Population Split, 1990-2020

GLOSSARY

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts
    Pharmaceuticals Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Business Environment Indicators
    Weighting
    Table: Weighting Of Components
    Sources
Skip to top


The Pharmaceutical Market: Croatia US$ 1,295.00 Jan, 2013 · 86 pages
The Pharmaceutical Market: Cuba US$ 1,295.00 Mar, 2013
The Pharmaceutical Market: Czech Republic US$ 1,295.00 Jan, 2013 · 90 pages
The Pharmaceutical Market: Denmark US$ 1,295.00 Mar, 2013
The Pharmaceutical Market: Egypt US$ 1,295.00 Jan, 2013 · 111 pages

Ask Your Question

The Pharmaceutical Market: Malaysia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: